These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9107153)

  • 1. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse.
    Bremner JD; Innis RB; Salomon RM; Staib LH; Ng CK; Miller HL; Bronen RA; Krystal JH; Duncan J; Rich D; Price LH; Malison R; Dey H; Soufer R; Charney DS
    Arch Gen Psychiatry; 1997 Apr; 54(4):364-74. PubMed ID: 9107153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.
    Neumeister A; Nugent AC; Waldeck T; Geraci M; Schwarz M; Bonne O; Bain EE; Luckenbaugh DA; Herscovitch P; Charney DS; Drevets WC
    Arch Gen Psychiatry; 2004 Aug; 61(8):765-73. PubMed ID: 15289275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects.
    Hasler G; Fromm S; Carlson PJ; Luckenbaugh DA; Waldeck T; Geraci M; Roiser JP; Neumeister A; Meyers N; Charney DS; Drevets WC
    Arch Gen Psychiatry; 2008 May; 65(5):521-31. PubMed ID: 18458204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.
    Neumeister A; Hu XZ; Luckenbaugh DA; Schwarz M; Nugent AC; Bonne O; Herscovitch P; Goldman D; Drevets WC; Charney DS
    Arch Gen Psychiatry; 2006 Sep; 63(9):978-86. PubMed ID: 16953000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.
    Bremner JD; Vythilingam M; Ng CK; Vermetten E; Nazeer A; Oren DA; Berman RM; Charney DS
    JAMA; 2003 Jun; 289(23):3125-34. PubMed ID: 12813118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.
    Ho AP; Gillin JC; Buchsbaum MS; Wu JC; Abel L; Bunney WE
    Arch Gen Psychiatry; 1996 Jul; 53(7):645-52. PubMed ID: 8660131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.
    Kennedy SH; Evans KR; Krüger S; Mayberg HS; Meyer JH; McCann S; Arifuzzman AI; Houle S; Vaccarino FJ
    Am J Psychiatry; 2001 Jun; 158(6):899-905. PubMed ID: 11384897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography study of the effects of tryptophan depletion on brain serotonin(2) receptors in subjects recently remitted from major depression.
    Yatham LN; Liddle PF; Sossi V; Erez J; Vafai N; Lam RW; Blinder S
    Arch Gen Psychiatry; 2012 Jun; 69(6):601-9. PubMed ID: 22664549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of regional brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography.
    Hagman JO; Buchsbaum MS; Wu JC; Rao SJ; Reynolds CA; Blinder BJ
    J Affect Disord; 1990 Jul; 19(3):153-62. PubMed ID: 2145335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.
    Smith KA; Morris JS; Friston KJ; Cowen PJ; Dolan RJ
    Br J Psychiatry; 1999 Jun; 174():525-9. PubMed ID: 10616631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.
    Delgado PL; Price LH; Miller HL; Salomon RM; Aghajanian GK; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1994 Nov; 51(11):865-74. PubMed ID: 7944875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.
    Brody AL; Saxena S; Stoessel P; Gillies LA; Fairbanks LA; Alborzian S; Phelps ME; Huang SC; Wu HM; Ho ML; Ho MK; Au SC; Maidment K; Baxter LR
    Arch Gen Psychiatry; 2001 Jul; 58(7):631-40. PubMed ID: 11448368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.
    Delgado PL; Charney DS; Price LH; Aghajanian GK; Landis H; Heninger GR
    Arch Gen Psychiatry; 1990 May; 47(5):411-8. PubMed ID: 2184795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study.
    Bauer M; Berman S; Stamm T; Plotkin M; Adli M; Pilhatsch M; London ED; Hellemann GS; Whybrow PC; Schlagenhauf F
    Mol Psychiatry; 2016 Feb; 21(2):229-36. PubMed ID: 25600111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sertraline on regional metabolic rate in patients with affective disorder.
    Buchsbaum MS; Wu J; Siegel BV; Hackett E; Trenary M; Abel L; Reynolds C
    Biol Psychiatry; 1997 Jan; 41(1):15-22. PubMed ID: 8988791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression.
    Rosa-Neto P; Diksic M; Okazawa H; Leyton M; Ghadirian N; Mzengeza S; Nakai A; Debonnel G; Blier P; Benkelfat C
    Arch Gen Psychiatry; 2004 Jun; 61(6):556-63. PubMed ID: 15184235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional neuroanatomy of the placebo effect.
    Mayberg HS; Silva JA; Brannan SK; Tekell JL; Mahurin RK; McGinnis S; Jerabek PA
    Am J Psychiatry; 2002 May; 159(5):728-37. PubMed ID: 11986125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroanatomic correlates of psychopathologic components of major depressive disorder.
    Milak MS; Parsey RV; Keilp J; Oquendo MA; Malone KM; Mann JJ
    Arch Gen Psychiatry; 2005 Apr; 62(4):397-408. PubMed ID: 15809407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder.
    Brody AL; Barsom MW; Bota RG; Saxena S
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):102-12. PubMed ID: 11296310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression.
    Wu JC; Gillin JC; Buchsbaum MS; Schachat C; Darnall LA; Keator DB; Fallon JH; Bunney WE
    J Affect Disord; 2008 Apr; 107(1-3):181-6. PubMed ID: 18031825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.